GlassScriptPhysician profile
Paul M Phillips
NPI 1922213107
$3,491.59
in general payments reported to CMS, 2019-2025
12 companies · $1,142 in 2025
The $1,142 reported for 2025 was more than what 80% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.02 · 2020: $198 · 2021: $703 · 2022: $374 · 2023: $309 · 2024: $723 · 2025: $1,142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,674 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,673.59 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,633.41 | 2019-2025 | Clareon, Hydrus Microstent, Centurion |
| Ivantis, INC | $721.93 | 2019-2021 | |
| Rxsight INC | $530.85 | 2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Sight Sciences, INC. | $175.50 | 2024 | Omni Surgical System |
| Glaukos Corporation | $124.82 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $118.83 | 2020 | |
| Allergan, INC. | $48.32 | 2021 | |
| Bausch & Lomb Americas INC. | $43.82 | 2022-2024 | Envista Mx60 Iol |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Biotissue Holdings INC. | $23.75 | 2025 | |
| Ziemer USA | $18.22 | 2024 | Femto Ldv, Femto Ldv |
| New World Medical,INC. | $13.34 | 2025 | Clearpath, Via360, Streamline |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.